Jazz Pharmaceuticals plc (J7Z) — Free Cash Flow Generation Index
Jazz Pharmaceuticals plc (J7Z) has a Free Cash Flow Generation Index of 0.95x as of March 2026. Free cash flow of €388.50 Million represents 1% of operating cash flow (€408.20 Million). Explore J7Z capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jazz Pharmaceuticals plc Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for Jazz Pharmaceuticals plc across 13 annual periods. For the full cash flow conversion analysis, see Jazz Pharmaceuticals plc operating cash flow efficiency.
Annual Free Cash Flow Generation for Jazz Pharmaceuticals plc (2013–2025)
Year-by-year Free Cash Flow Generation Index for Jazz Pharmaceuticals plc. Check Jazz Pharmaceuticals plc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | €1.15 Billion | €1.36 Billion | €209.75 Million | ▼ -12.5% |
| 2024 | 0.97x | €1.35 Billion | €1.40 Billion | €48.07 Million | ▲ +0.5% |
| 2023 | 0.96x | €1.05 Billion | €1.09 Billion | €42.96 Million | ▼ -3.9% |
| 2022 | 1.00x | €1.27 Billion | €1.27 Billion | €29.05 Million | ▲ +6.2% |
| 2021 | 0.94x | €732.98 Million | €778.51 Million | €27.64 Million | ▲ +62.8% |
| 2020 | 0.58x | €520.39 Million | €899.65 Million | €15.00 Million | ▼ -24.4% |
| 2019 | 0.77x | €594.07 Million | €776.40 Million | €40.13 Million | ▼ -8.4% |
| 2018 | 0.84x | €667.43 Million | €798.90 Million | €20.37 Million | ▼ 0.0% |
| 2017 | 0.84x | €579.14 Million | €693.09 Million | €28.95 Million | ▼ -36.0% |
| 2016 | 1.31x | €773.97 Million | €592.39 Million | €181.58 Million | ▲ +22.4% |
| 2015 | 1.07x | €567.90 Million | €531.94 Million | €35.96 Million | ▼ -2.0% |
| 2014 | 1.09x | €443.95 Million | €407.61 Million | €36.35 Million | ▲ +5.3% |
| 2013 | 1.03x | €298.41 Million | €288.43 Million | €9.98 Million | — |